论文部分内容阅读
目的:对孟鲁司特钠对轻度持续哮喘患儿临床治疗效果分析。方法:选取2010年10月~2012年10月我院收治的轻度持续哮喘患儿144例,随机分为2组,治疗组70例,在常规治疗基础上联合孟鲁司特钠进行治疗;对照组74例,采用单纯常规治疗,对比2组患儿的的临床疗效。结果:治疗组患儿的临床治疗效果、住院治疗时间、呼吸困难缓解的时间、复发率均显著低于观察组患儿,差异性明显,具有统计学意义(P<0.05)。2组患儿均未发生因治疗导致的严重不良反应。结论:针对小儿轻度哮喘应用孟鲁司特进行临床治疗,可显著提高患儿的临床有效率;缩短住院治疗时间、减少呼吸困难缓解的时间、显著降低复发率,无严重不良反应,适宜临床广泛应用治疗。
Objective: To analyze the clinical effect of montelukast on children with mild persistent asthma. Methods: A total of 144 mild persistent asthma children admitted to our hospital from October 2010 to October 2012 were randomly divided into two groups. The treatment group was treated with montelukast sodium on the basis of routine treatment. The control group of 74 cases, using simple routine treatment, compared with the clinical efficacy of two groups of children. Results: The clinical efficacy, hospitalization time, time to relief of dyspnea and recurrence in children in the treatment group were significantly lower than those in the observation group, with significant difference (P <0.05). No serious adverse reactions to treatment resulted from the two groups of children. Conclusion: The clinical treatment of montelukast in children with mild asthma can significantly improve the clinical efficacy of children; shorten the hospital treatment time and reduce the time to alleviate the respiratory distress, significantly reduce the recurrence rate, no serious adverse reactions, suitable for clinical Widely used treatment.